Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer
1997

Detecting Micrometastatic Prostate Cancer Cells in Bone Marrow

Sample size: 35 publication Evidence: moderate

Author Information

Author(s): T Deguchi, M Yang, H Ehara, S Ito, Y Nishino, Y Takahashi, Y Ito, K Shimokawa, T Tanaka, T Imaeda, T Doi, Y Kawada

Primary Institution: Gifu University School of Medicine

Hypothesis

Can reverse transcription-polymerase chain reaction (RT-PCR) detect micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer?

Conclusion

RT-PCR can detect micrometastatic prostate cancer cells in the bone marrow that are not visible through traditional bone scan imaging.

Supporting Evidence

  • Of 35 patients, 14 had metastatic bone diseases including micrometastases.
  • RT-PCR detected PSA mRNA in 7 of 26 patients with negative bone scans.
  • Patients with a serum PSA concentration of 25 ng/ml or greater had a significantly higher risk of bone involvement.

Takeaway

Doctors can find tiny cancer cells in the bone marrow of prostate cancer patients using a special test, even when other tests say there are no cancer signs.

Methodology

The study used RT-PCR to analyze bone marrow samples from 35 prostate cancer patients to detect PSA mRNA expression.

Limitations

The study had a small sample size and insufficient information about the clinical significance of bone marrow micrometastases.

Participant Demographics

All participants were Japanese men with prostate cancer confirmed by histology.

Statistical Information

P-Value

p<0.01

Confidence Interval

71.3-100%

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication